ChromaCode

ChromaCode Partners With Medical College of Georgia on Non-Small Cell Lung Cancer Rapid PCR Testing

The college's department of pathology will work with the company to further validate a lung cancer genotyping assay developed using ChromaCode's HDPCR technology.

ChromaCode, Protean BioDiagnostics Partner to Launch Lung Cancer Test

The test uses ChromaCode's High Definition PCR multiplexing technology and detects all National Comprehensive Cancer Network recommended variants in less than 24 hours.

ChromaCode

ChromaCode Partners With Medical College of Georgia on Non-Small Cell Lung Cancer Rapid PCR Testing

ChromaCode, Protean BioDiagnostics Partner to Launch Lung Cancer Test

UK's NICE Reverses Course on Immunocore's Kimmtrak for Advanced Uveal Melanoma

Epsilogen Launches Phase Ib IgE Antibody Trial in Advanced Ovarian Cancer

Novartis Pens $2.9B Deal With PTC Therapeutics for Huntington's Disease Drug

Final FDA Guidance Lays Path for Drugmakers to Establish Circulating Tumor DNA as Trial Endpoint

Merck, Moderna Vax Trial Starts Enrolling Lung Cancer Patients at McGill University Health Center

Senti Biosciences Announces $37.6M PIPE Financing, Reports Early Data From Phase I CAR-NK Trial